Comparative efficacy and acceptability of antimanic drugs in acute mania: A multiple-treatments meta-analysis

The Lancet

Volumn 378, Issue 9799, 2011, Pages 1306-1315

  Cipriani, Andrea ^a   Barbui, Corrado ^a   Salanti, Georgia ^b   Rendell, Jennifer ^c   Brown, Rachel ^c   Stockton, Sarah ^c   Purgato, Marianna ^a   Spineli, Loukia M ^b   Goodwin, Guy M ^c   Geddes, John R ^c  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF IOANNINA   (Greece)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; ASENAPINE; CARBAMAZEPINE; GABAPENTIN; HALOPERIDOL; LAMOTRIGINE; LITHIUM; OLANZAPINE; PLACEBO; QUETIAPINE; RISPERIDONE; TOPIRAMATE; TRANQUILIZER; VALPROIC ACID; ZIPRASIDONE;

ACUTE DISEASE; ARTICLE; COMPARATIVE STUDY; DRUG EFFICACY; HUMAN; MANIA; META ANALYSIS; MULTIPLE CYCLE TREATMENT; PATIENT ATTITUDE; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 80053925799     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)60873-8     Document Type: Article

References (30)

1. CJ Murray, AD Lopez Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study Lancet 349 1997 1436 1442 (Pubitemid 27212192)
2. NICE clinical guideline 38 Bipolar disorder: the management of bipolar disorder in adults, children 30 and adolescents, in primary and secondary care (2006) Available at http://www.nice.org.uk/CG038 (accessed July 28, 2011).
3. H Scherk, FG Pajonk, S Leucht Second-generation antipsychotic agents in the treatment of acute 2 mania: a systematic review and meta-analysis of randomized controlled trials Arch Gen Psychiatry 64 2007 442 455 (Pubitemid 46556468)
4. GM Goodwin Consensus Group of the British Association for Psychopharmacology Evidence-based guidelines for treating bipolar disorder: revised 2nd edn - recommendations from the British Association for Psychopharmacology J Psychopharmacol 23 2009 346 388
5. CU Correll, EM Sheridan, MP DelBello Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials Bipolar Disord 12 2010 116 141
6. JM Tamayo, CA Zarate Jr, E Vieta, G Vázquez, M Tohen Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysis Int J Neuropsychopharmacol 13 2010 813 832
7. A Yildiz, E Vieta, S Leucht, RJ Baldessarini Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials Neuropsychopharmacology 36 2011 375 389
8. DM Caldwell, AE Ades, JP Higgins Simultaneous comparison of multiple treatments: combining direct and indirect evidence BMJ 331 2005 897 900 (Pubitemid 41502718)
9. G Salanti, JP Higgins, AE Ades, JP Ioannidis Evaluation of networks of randomized trials Stat Methods Med Res 17 2008 279 301
10. A Cipriani, TA Furukawa, G Salanti et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis Lancet 373 2009 746 758
11. JPT Higgins, DG Altman, JAC Sterne Chapter 8: Assessing risk of bias in included studies JPT Higgins S Green Cochrane handbook for systematic reviews of interventions version 5.1.0 2011 The Cochrane Collaboration http://www.cochrane-handbook.org (accessed July 28, 2011).
12. M Purgato, C Barbui, A Cipriani Assessing risk of bias in randomized controlled trials Epidemiol Psichiatr Soc 19 2010 296 297
13. RC Young, JT Biggs, VE Ziegler, DA Meyer A rating scale for mania: reliability, validity and sensitivity Br J Psychiatry 133 1978 429 435 (Pubitemid 9006756)
14. R DerSimonian, N Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188 (Pubitemid 17189972)
15. JPT Higgins, S Green Cochrane handbook for systematic reviews of interventions version 5.0.2 (updated September, 2009) 2009 The Cochrane Collaboration http://www.cochrane-handbook.org (accessed July 28, 2011).
16. JP Higgins, SG Thompson, JJ Deeks, DG Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560 (Pubitemid 37088507)
17. G Lu, AE Ades Combination of direct and indirect evidence in mixed treatment comparisons Stat Med 23 2004 3105 3124 (Pubitemid 39334902)
18. AE Ades, M Sculpher, A Sutton et al. Bayesian methods for evidence synthesis in cost-effectiveness analysis Pharmacoeconomics 24 2006 1 19 (Pubitemid 43197227)
19. G Salanti, AE Ades, JP Ioannidis Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial J Clin Epidemiol 64 2011 163 171
20. G Salanti, V Marinho, JP Higgins A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered J Clin Epidemiol 62 2009 857 864
21. S Dias, NJ Welton, DM Caldwell, AE Ades Checking consistency in mixed treatment comparison meta-analysis Stat Med 29 2010 932 944
22. H Grunze, E Vieta, GM Goodwin et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania World J Biol Psychiatry 10 2009 85 116
23. LN Yatham, SH Kennedy, A Schaffer et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009 Bipolar Disord 11 2009 225 255
24. WHO WHO model list of essential medicines 16th list. World Health Organization http://www.who.int/medicines/publications/essentialmedicines/ Updated-sixteenth-adult-list-en.pdf (accessed Jan 19, 2011).
25. S Leucht, C Corves, D Arbter, RR Engel, C Li, JM Davis Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis Lancet 373 2009 31 41
26. RS Kahn, WW Fleischhacker, H Boter EUFEST study group Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial Lancet 371 2008 1085 1097 (Pubitemid 351418005)
27. C Rummel-Kluge, K Komossa, S Schwarz et al. Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis Schizophr Res 123 2010 225 233
28. RW Licht Limitations in randomised controlled trials evaluating drug effects in mania Eur Arch Psychiatry Clin Neurosci 251 2001 S66 S71
29. K Soares-Weiser, Y Bravo Vergel, S Beynon et al. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder Health Technol Assess 11 2007 1 226
30. JR Geddes, GM Goodwin, J Rendell et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial Lancet 375 2010 385 395